| Literature DB >> 25749337 |
Qian Che1, Ling Lin1, Qing Ai2, Pu Ge1, Jie Dai3, Rong Jiang4, Dan Zhou1, Jingyuan Wan5, Li Zhang6.
Abstract
The glycolytic inhibitor 2-deoxyglucose (2-DG) is a calorie restriction (CR) mimetic produces CR-like beneficial effects in both acute and chronic pathological processes, but whether 2-DG is also helpful in critical and life-threatening situation is not known. In the present study, the potential benefits of 2-DG in lipopolysaccharide/D-galactosamine (LPS/D-Gal)-induced lethal liver injury were investigated. The results indicated that treatment with 2-DG suppressed the elevation of plasma aminotransferases, alleviated the histopathological abnormalities and improved the survival rate of LPS/D-Gal-exposed mice. Treatment with 2-DG also suppressed the production of pro-apoptotic cytokine TNF-α, the phosphorylation of JNK, the activation of caspase cascade and the count of TUNEL-positive apoptotic hepatocytes. These data suggested that the CR mimetic 2-DG could also provide beneficial effects in lethal pathological process such as LPS/D-Gal-induced fulminant liver injury.Entities:
Keywords: 2-Deoxyglucose; Calorie restriction mimetic; Lipopolysaccharide; Liver injury
Mesh:
Substances:
Year: 2015 PMID: 25749337 DOI: 10.1016/j.bbrc.2015.02.145
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575